|
Real-time Estimate
Cboe BZX
20:59:55 07/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.715 USD | -0.55% |
|
-1.45% | +51.11% |
| Market Cap | 220M 197M 183M 167M 314M 21.28B 316M 2.2B 861M 10.82B 826M 808M 34.79B | P/E 2026 * |
11.4x | P/E 2027 * | 54.6x |
|---|---|---|---|---|---|
| Enterprise Value | 220M 197M 183M 167M 314M 21.28B 316M 2.2B 861M 10.82B 826M 808M 34.79B | EV / Sales 2026 * |
2.68x | EV / Sales 2027 * | 3.31x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PLX | Delayed | |
CBOE
| PLX | Real-time | |
Boerse Muenchen
| PBDA | Real-time | |
Tradegate
| PBDA | Real-time | |
Börse Stuttgart
| PBDA | Delayed | |
Deutsche Boerse AG
| PBDA | Delayed |
Last Transcript: Protalix BioTherapeutics, Inc.
| 1 day | -0.37% | ||
| 1 week | -1.45% | ||
| Current month | -1.45% | ||
| 1 month | +2.64% | ||
| 3 months | +15.25% | ||
| 6 months | +24.20% | ||
| Current year | +51.11% |
| 1 week | 2.6 | 2.77 | |
| 1 month | 2.6 | 2.85 | |
| Current year | 1.72 | 3.19 | |
| 1 year | 1.6 | 3.19 | |
| 3 years | 0.82 | 3.19 | |
| 5 years | 0.7 | 3.55 | |
| 10 years | 0.7 | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 29/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 23/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 30/06/2008 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 31/10/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 29/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/09/26 | Free | Director | 25,500 | 0.0316% | ||
| 03/09/26 | Free | Chairman | 25,500 | 0.0316% | ||
| 03/09/26 | Free | Chief Executive Officer | 480,000 | 0.5957% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.55% | -1.45% | +8.80% | +77.78% | 220M | ||
| +2.70% | +2.72% | +40.88% | +107.87% | 1,032B | ||
| +1.49% | -2.22% | +37.04% | +63.27% | 614B | ||
| +1.82% | +3.77% | +16.59% | +82.06% | 471B | ||
| +0.61% | -1.80% | +62.86% | +36.54% | 350B | ||
| +2.92% | +3.06% | +24.83% | +45.10% | 337B | ||
| +2.42% | -0.74% | +13.44% | +35.80% | 268B | ||
| +1.86% | -0.81% | -4.69% | +12.20% | 246B | ||
| +2.40% | -2.01% | +39.76% | +52.12% | 218B | ||
| +1.79% | -1.43% | +25.81% | +95.74% | 179B | ||
| Average | +1.57% | -2.98% | +26.53% | +60.85% | 371.51B | |
| Weighted average by Cap. | +1.93% | -3.18% | +31.99% | +69.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 82.16M 73.41M 68.49M 62.21M 117M 7.95B 118M 823M 322M 4.04B 308M 302M 12.99B | 66.48M 59.4M 55.42M 50.34M 94.8M 6.43B 95.51M 666M 260M 3.27B 250M 244M 10.51B |
| Net income | 19.63M 17.54M 16.37M 14.86M 28M 1.9B 28.21M 197M 76.83M 966M 73.7M 72.11M 3.1B | 3.79M 3.39M 3.16M 2.87M 5.41M 367M 5.45M 38.01M 14.85M 187M 14.24M 13.94M 600M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/10/26 | US$2.700 | -1.10% | 643,064 |
| 06/10/26 | US$2.730 | +0.74% | 934,737 |
| 05/10/26 | US$2.710 | 0.00% | 984,060 |
| 02/10/26 | US$2.710 | +1.12% | 947,405 |
| 01/10/26 | US$2.680 | -2.90% | 1,589,280 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions

















